AIM
IDXX icon

AXA Investment Managers’s Idexx Laboratories IDXX Stock Holding History

AXA Investment Managers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.8M Buy
+32,588
New +$19.8M 0.06% 282

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

AXA Investment Managers's IDXX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Idexx Laboratories (IDXX) in Q3 2025: 32,588 shares worth $20.8M. The stake represents 0.06% of the portfolio and ranks #282 among its holdings.

1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • AXA Investment Managers held 32,588 shares of Idexx Laboratories worth $20.8M as of Q3 2025.
  • Idexx Laboratories was a new AXA Investment Managers position in Q3 2025.
  • Idexx Laboratories made up 0.06% of AXA Investment Managers's portfolio in Q3 2025, its #282 holding.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.